Given MIF's established disease‐aggravating roles in acute respiratory distress syndrome (ARDS), we here aimed to study potential immunomodulatory cross‐kingdom interactions between MIF and MDL1 in an in vivo mouse model of ALI, which reflects the acute and sub‐acute phases of ARDS.5, 7. This evidence concerns the gene MIF and acute respiratory distress syndrome.